Modified Thoracoscopic Pleural Cryobiopsy in Diagnosis of Exudative Pleural Effusion
1 other identifier
interventional
24
1 country
1
Brief Summary
Background: Rigid thoracoscopy is the gold standard tool for diagnosing exudative pleural effusion but sometimes it is difficult to obtain sufficient biopsies using the conventional forceps. Objectives: This study evaluated the efficacy, safety and diagnostic value of a modified technique using cryoprobe to obtain pleural biopsies during thoracoscopy. Methods: This is a single center prospective study in patients who will undergo rigid thoracoscopy using conventional rigid forceps followed by a cryoprobe from the same site after injection of subpleural mixture of adrenaline and xylocaine. Biopsies will be reviewed by an independent pathologist; any complications will be recorded, and all patients will be followed up post procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 11, 2020
CompletedFirst Submitted
Initial submission to the registry
December 5, 2020
CompletedFirst Posted
Study publicly available on registry
December 24, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 10, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2021
CompletedDecember 24, 2020
December 1, 2020
2 months
December 5, 2020
December 19, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Comparison between pleural biopsy specimens obtained by modified cryoprobe technique and conventional rigid forceps during medical thoracoscopy in diagnosis of pleural effusion regarding size of the obtained pleural biopsies.
Size of the pleural biopsies obtained by both procedures will be compared in millimeters
Immediately after ending the procedure
Comparison between pleural biopsy specimens obtained by modified cryoprobe technique and conventional rigid forceps during medical thoracoscopy in diagnosis of pleural effusion regarding depth of the obtained pleural biopsies.
Depth of the pleural biopsies obtained by both procedures will be compared by "grading of fat cells" Grading will be as follows: if there will be no presence of fat cells, this will be marked as negative and if less than 5% of the biopsy will be marked as + and if 5-25% of the biopsy will be marked as ++ and if more than 25% it will take +++ in both limbs of the cryo and forceps techniques.
1 week
Comparison between pleural biopsy specimens obtained by modified cryoprobe technique and conventional rigid forceps during medical thoracoscopy in diagnosis of pleural effusion regarding integrity of the obtained pleural biopsies.
Integrity of the pleural biopsies obtained by both procedures will be compared by percentage of "crushed cells."" Grading will be as follows: if there will be no presence of crushed cells, this will be marked as negative and if less than 5% of the biopsy will be marked as + and if 5-25% of the biopsy will be marked as ++ and if more than 25% it will take +++ in both limbs of the cryo and forceps techniques.
1 week
Secondary Outcomes (1)
Safety of the procedure of thoracoscopic pleural biopsies
During the period of hospital stay
Study Arms (1)
Patients with pleural effusion of Undetermined etiology
EXPERIMENTALPatients with undiagnosed exudative pleural effusion will undergo modified pleural cryobiopsies and conventional pleural forceps biopsies in the same settings
Interventions
Thoracoscopic pleural biopsy will be taken with a modified technique "raising of the parietal pleura by injection of saline, adrenaline and xylocaine, then taking the biopsy via a cryoprobe"
Eligibility Criteria
You may qualify if:
- Adult patient with undiagnosed exudative pleural effusion
You may not qualify if:
- Any contraindications to medical thoracoscopy like:
- Inability to tolerate lateral decubitus position Unstable cardiovascular or hemodynamic status Presence of severe, uncorrectable hypoxemia despite oxygen therapy Bleeding diathesis Refractory cough Drug Hypersensitivity Reduced general health status with short suspected survival
- Refusal to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chest Department, Alexandria Faculty of Medicine
Alexandria, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ayman I Baess, PhD
Associate Professor of Chest diseases, Alexandria University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 5, 2020
First Posted
December 24, 2020
Study Start
November 11, 2020
Primary Completion
January 10, 2021
Study Completion
January 15, 2021
Last Updated
December 24, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share
Data should be confirmed in larger, multi-sites studies.